Distal Medium Vessel Occlusion Strokes: Understanding the Present and Paving the Way for a Better Future
Raul G. Nogueira, Mohamed Fahmy Doheim, Alhamza R Al‐Bayati, Jin Soo Lee, Diogo C Haussen, Mahmoud Mohammaden, Michael J. Lang, Matthew Starr, Marcelo Borges Rocha, Catarina Perry da Câmara, Bradley A. Gross, Nirav Bhatt
Abstract
Distal medium vessel occlusions (DMVOs) are thought to cause as many as 25% to 40% of all acute ischemic strokes and may result in substantial disability amongst survivors. Although intravenous thrombolysis (IVT) is more effective for distal than proximal vessel occlusions, the overall efficacy of IVT remains limited in DMVO with less than 50% of patients achieving reperfusion and about 1/3 to 1/4 of the patients failing to achieve functional independence. Data regarding mechanical thrombectomy (MT) among these patients remains limited. The smaller, thinner, and more tortuous vessels involved in DMVO are presumably associated with higher procedural risks whereas a lower benefit might be expected given the smaller amount of tissue territory at risk. Recent advances in technology have shown promising results in endovascular treatment of DMVOs with room for future improvement. In this review, we discuss some of the key technical and clinical considerations in DMVO treatment including the anatomical and clinical terminology, diagnostic modalities, the role of IVT and MT, existing technology, and technical challenges as well as the contemporary evidence and future treatment directions.